Skip to content

A multi-center study on the reduction of postoperative recurrence rate of complicated hepatolithiasis by Dachaihutangjiawei

A multi-center study on the reduction of postoperative recurrence rate of complicated hepatolithiasis by Dachaihutangjiawei

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040586
Enrollment
Unknown
Registered
2020-12-03
Start date
2020-12-02
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

complicated hepatolithiasis

Interventions

Sponsors

Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Between the ages of 18 and 60 years; (2) All patients were diagnosed as intrahepatic bile duct stones by ultrasound, CT, MRI and other clinically assisted examinations, and met the diagnostic criteria and underwent surgical treatment; (3) All patients voluntarily signed informed consent to cooperate with the study, and this study was approved by the Hospital Ethics Association.

Exclusion criteria

Exclusion criteria: (1) Patients with severe acute biliary tract infection;Acute abdominal disease, tumor, acute cholecystitis; (2) Patients with severe heart, liver, kidney, blood system diseases and other visceral dysfunction;Psychopath (3) Patients with acute severe pancreatitis; (4) Poor compliance, do not cooperate with the treatment. (5) Pregnant or lactating women, patients with hypersensitive constitution and those who are intolerant to this drug; (6) Those who have not signed the informed consent.

Design outcomes

Primary

MeasureTime frame
magnetic resonance cholangiopancreatography;T tube imaging;White blood cells;Alanine aminotransferase;Rice straw transaminase;Total bilirubin;Direct bilirubin;Indirect bilirubin;Total cholesterol;Bile drainage;

Countries

China

Contacts

Public ContactXu Ning

Second Affiliated Hospital of Kunming Medical University

30624295@qq.com+86 13708854244

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026